SLS

SELLAS Life Sciences Group (SLS)

About SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Details

Daily high

$5.58

Daily low

$4.93

Price at open

$5.40

52 Week High

$6.14

52 Week Low

$0.95

Market cap

780.6M

Dividend yield

0.00%

Volume

8.5M

Avg. volume

8.4M

P/E ratio

-22.29

SELLAS Life Sciences Group News